Piperacillin, chemically (2S,5R,6R)-6-[(R)-2-(4-ethyl-2,3 dioxo-1-piperazine carboxamido)-2-phenylacetamido]-3,3 dimethyl-7-oxo-4-thia-1-azabicyclo-[3.2.0]-heptane-2 carboxylic acid-monohydrate, is a broad spectrum, semisynthetic, ureido-penicillin www.ijpsonline.com been reported in biological samples 8 . In a method reported for estimation of piperacillin and tazobactam in injection formulation 9 , the net retention time was found to be around 15 min. The objective of the proposed method was to select a new system of simple mobile phase that provides rapid separation with low retention time and good resolution of peaks.
An HPLC system from Shimadzu (LC 10AT-VP) fitted with a Rheodyne injector, UV detector (SPD 10A-VP) and Winchrome software for processing the data generated was detector response was found to be linear over the concentration range of 10-80 µg/ml and 2-10 µg/ml for piperacillin and tazobactam respectively. The method was validated for statistical parameters like precision, accuracy, specificity, linearity, range, ruggedness and robustness. Results of the method validation experiments and precision were determined by three replicate solutions of the two independent samples. Sample solution was prepared from different batches of marketed formulation Tazact. Powder for injection, 12.6 used. Analysis was carried out using Wakosil C18 column mg, equivalent to 10 mg of piperacillin and 1.2 mg of (SGE), 5 µm, 4.6 × 250 mm, with a flow rate of 1 ml/min. tazobactam was weighed into 10 ml volumetric flask. The UV detection was carried out at 220 nm. Acetonitrile HPLC powder was dissolved in the mobile phase and volume grade, methanol HPLC grade, sodium dihydrogen made up to 10 ml to obtain sample stock solution. orthophosphate AR grade and orthophosphoric acid were Further, 0.5 ml of the sample stock solution was diluted used for the analysis. Millipore water was used in the to 10 ml with mobile phase to obtain working sample process. The phosphate buffer pH 4 was prepared by the solution of 50 µg/ml. The working sample solution was following method. Sodium dihydrogen orthophosphate injected into the chromatograph, and the compounds dihydrate, 71.63 g, was dissolved and volume made up to piperacillin and tazobactam were found to show 1000 ml with water. The pH was adjusted to 4 with satisfactory separation with retention time of 6.4 min and orthophosphoric acid. Volume of 250 ml each of methanol 3.1 min respectively. and acetonitrile was mixed with 500 ml of phosphate buffer, sonicated for 5 min and used as mobile phase. Injection
The accuracy of the method was determined by adding formulation of combined piperacillin and tazobactam, known amounts of standard to those of sample at four Tazact, Cipla Ltd., Batch No ZB4015 and ZB5030, was levels, keeping the sample concentration constant. The purchased from a local pharmacy.
recovery study data is presented in Table 1 . The precision of the method was determined by replicate To obtain standard calibration curve, the following injections of standard solution. The percent RSD of the procedure was adopted. About 10 mg each of piperacillin assay was found to be 0.68% for piperacillin and 0.78% and tazobactam were weighed into separate 10 ml for tazobactam, indicating high degree of precision and volumetric flasks, dissolved with the mobile phase and reproducibility. The precision of the system was volume made up with the same solvent to obtain standard determined for replicate samples by multiple injections of stock solution. By dilution, working standard solutions of a set of solutions of the same concentration of piperacillin piperacillin and tazobactam of concentration 50 µg/ml and tazobactam. The instrument response was found to were prepared from the standard stock solution. The be reproducible as found from percent RSD of 0.71% for working standard solutions were injected into the piperacillin and 0.70% for tazobactam. chromatograph. The retention time for piperacillin and tazobactam was found to be 6.4 and 3.1 min, respectively.
The robustness was determined by carrying out the Calibration curves were obtained by plotting mean peak assay during which the mobile phase ratio and pH of the areas against the corresponding drug concentration. The mobile phase was altered slightly. When the pH was www.ijpsonline.com altered to 4.5, percent RSD was found to be 0.15% for piperacillin and 0.6% for tazobactam. On slight variation in the mobile phase ratio of up to ±10%, the percent RSD was 0.2% for piperacillin and 0.1% for tazobactam, which indicated that the method is robust, also indicating lack of influence on the test results by operational variables for the proposed method.
The ruggedness of the method was determined by performing the same assay by different analysts and performing the assay on different days to check the Estimation of piperacillin and tazobactam in the marketed formulation gave assay results of 99.9-100.7% and 99.7 102.8%, respectively. The proposed method is thus precise, accurate, rugged, robust and can be conveniently used for the estimation of piperacillin and tazobactam in their injection formulation.
